e, Moazami was able to persuade them to allow the compassionate use of the experimental device for Guthrie.
"We had no choice with this gentleman," he said. "He was too healthy not to do anything, but he was stuck in the ICU."
Once the new device was implanted, Guthrie recovered remarkably. His kidney function and physical strength returned, and he got out of the ICU. He has not yet regained his appetite, but "given what he's been through, this is minor," Moazami said.
"He's got nine lives. I think we've used eight of them."
Barnes-Jewish doctors are familiar with HeartMate II because the hospital is one of the institutions participating in the clinical trial.
A small pump implanted in the body, it is attached to a half-inch cable connected to a battery pack that recharges it. It's mobile. Moazami said one of his patients in the clinical trial delivers pizzas.
The device will stay inside Guthrie, and he should do well, as long as it's durable perhaps as long as five years. When it fails, he'll either get a replacement or be considered for a heart transplant.
Guthrie should be hoping to pull through, along with the physicians,not to speak of the HeartMate II manufacturers.Page: 1 2 Related medicine news :1
. One in Three Heart Attack Patients Have No Chest Pains
. Amphetamines Help Recovery of Stroke Patients
. Painkillers Do Not Shorten Dying Patients Lives
. Patients With Filariasis More Prone To HIV Infection5
. Glivec - New Hope For CMC Patients6
. Patient’s perception of health status helps in better recover7
. Patients often assume wrongly that they are allergic to penicillin8
. New FDA Approved Drug NATRECOR For Heart Failure Patients9
. Hemochromatosis Patients Blood is Safe 10
. Fifth US Patient Receives Artificial Heart
. Patients Pressure Would Result In Overprescription